Alcon Inc. (ALC)

USD 93.74

(2.58%)

Long Term Debt Summary of Alcon Inc.

  • Alcon Inc.'s latest annual long term debt in 2023 was 4.59 Billion USD , down -6.28% from previous year.
  • Alcon Inc.'s latest quarterly long term debt in 2024 Q2 was 4.54 Billion USD , down -0.07% from previous quarter.
  • Alcon Inc. reported annual long term debt of 4.9 Billion USD in 2022, up 13.82% from previous year.
  • Alcon Inc. reported annual long term debt of 4.3 Billion USD in 2021, up 0.96% from previous year.
  • Alcon Inc. reported quarterly long term debt of 4.88 Billion USD for 2024 Q1, down -0.89% from previous quarter.
  • Alcon Inc. reported quarterly long term debt of 4.57 Billion USD for 2023 Q2, up 0.05% from previous quarter.

Annual Long Term Debt Chart of Alcon Inc. (2023 - 2015)

Historical Annual Long Term Debt of Alcon Inc. (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 4.59 Billion USD -6.28%
2022 4.9 Billion USD 13.82%
2021 4.3 Billion USD 0.96%
2020 4.26 Billion USD 21.9%
2019 3.49 Billion USD 3830.34%
2018 89 Million USD 5.95%
2017 84 Million USD 6.33%
2016 79 Million USD 5.33%
2015 75 Million USD 0.0%

Peer Long Term Debt Comparison of Alcon Inc.

Name Long Term Debt Long Term Debt Difference
AptarGroup, Inc. 726.45 Million USD -532.172%
Baxter International Inc. 11.06 Billion USD 58.492%
Becton, Dickinson and Company 14.73 Billion USD 68.839%
Bausch + Lomb Corporation 4.53 Billion USD -1.334%
Haemonetics Corporation 797.56 Million USD -475.809%
Envista Holdings Corp 1.5 Billion USD -204.539%
ResMed Inc. 697.31 Million USD -558.592%
Teleflex Incorporated 1.83 Billion USD -149.742%
Warby Parker Inc. 150.17 Million USD -2958.143%
West Pharmaceutical Services, Inc. 157.3 Million USD -2819.545%